Pulmonary ascorbic acid loss induced by catecholamines.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism*; D001835:Body Weight; D003994:Bucladesine / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008168:Lung / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000494:pharmacology; D009929:Organ Size; D010643:Phenoxybenzamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011654:Pulmonary Edema / Q000139:chemically induced; D012701:Serotonin / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D010643:Phenoxybenzamine; D010656:Phenylephrine; D012701:Serotonin; D003994:Bucladesine; D006632:Histamine; D011433:Propranolol; D007545:Isoproterenol; D001205:Ascorbic Acid; D009638:Norepinephrine; D004837:Epinephrine